Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: Results of an open-label study

Clinical Therapeutics

Volumn 25, Issue 1, 2003, Pages 298-308

  Campanati, Anna ^a,b   Penna, Luca ^a   Guzzo, Teresa ^a   Menotta, Lucia ^a   Silvestri, Barbara ^a   Lagalla, Giovanni ^a   Gesuita, Rosaria ^a   Offidani, Annamaria ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Clinica Dermatologica   (Italy)

Author keywords

Botulinum toxin type A; Focal hyperhidrosis; Quality of life

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERHIDROSIS; MALE; PHYSIOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; SWEATING;

EID: 0037277488     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)90041-5     Document Type: Article

References (26)

1. Bovel DL, Clunes MT, Elder HY, et al. Ultrastructure of the hyperhidrotic sweat gland. Br J Dermatol. 2001;145:298-301.
2. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox. Dermatol Surg. 1998;24:817-819.
3. Pearce LB, First ER, MacCallum RD, Gupta A. Pharmacologic characterization of botulinum toxin for basic science and medicine. Toxicon. 1997;35:1373-1412.
4. Naumann M. Evidence-based medicine: Botulinum toxin in focal hyperhidrosis. J Neurol. 2001;248(Suppl 1):31-33.
5. Naver H, Aquilonius S-M. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol. 1997;4(Suppl 2):S75-S79.
6. Schnider P, Binder M, Auff E, et al. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 1997;136:548-552.
7. Shelley WB, Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol. 1998;38:227-229.
8. Schnider P, Binder M, Kittler H, et al. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol. 1999;140:677-680.
9. Naver H, Swartling C, Aquilonius S-M. Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience. Eur J Neurol. 1999;6(Suppl 4):S117-S120.
10. Naver H, Swartling C, Aquilonius S-M. Palmar and axillary hyperhidrosis treated with botulinum toxin: One-year clinical follow-up. Eur J Neurol. 2000;7:55-62.
11. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol. 2000;42:1026-1029.
12. Karamfilov T, Konrad H, Karte K, Wollina U. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase. Arch Dermatol. 2000;136:487-490.
13. Naumann M, Lowe N. Botulinum toxin type A in treatment of bilateral axillary hyperhidrosis: Randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323:596-599.
14. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344:488-493.
15. Heckmann M, Breit S, Ceballos-Baumann A, et al. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol. 1999;41:987-990.
16. Naumann M, Hofmann U, Bergmann I, et al. Focal hyperhidrosis: Effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301-304.
17. Naumann M, Bergmann I, Hofmann U, et al. Botulinum toxin for focal hyperhidrosis: Technical considerations and improvements in application. Br J Dermatol. 1998;139:1123-1124.
18. Braune C, Erbguth F, Birklein F. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: Measured by sudometry. Br J Dermatol. 2001;144:111-117.
19. Odderson IR. Axillary hyperhidrosis: Treatment with botulinum toxin A. Arch Phys Med Rehabil. 1998;79:350-352.
20. Schnider P, Moraru E, Kittler H, et al. Treatment of focal hyperhidrosis with botulinum toxin type A: Long-term follow-up in 61 patients. Br J Dermatol. 2001;145:289-293.
21. Vadoud-Seyedi J, Simonart T, Heenen M. Treatment of plantar hyperhidrosis with dermojet injections of botulinum toxin. Dermatology. 2001;201:179.
22. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
23. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol. 2001;8:247-252.
24. Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: A comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672-676.
25. Lundberg L, Johannesson M, Silverdahl M, et al. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol. 1999;141:1067-1075.
26. Hahn HB, Melfi CA, Chuang TY, et al Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. J Am Acad Dermatol. 2001;45:44-48.